Health
New Study From GENinCode Shows Polygenic Risk Scores Improve the Accuracy of Cardiovascular Disease Risk Prediction
NEW ORLEANS, LOUISIANA / ACCESS Newswire / November 12, 2025 / American Heart Association ("AHA") Conference 2025, GENinCode the predictive genetics company focused on the prevention of cardiovascular disease ("CVD"), announces the presentation by ...
About this update from Genincode Plc
[{"type":"text","content":"NEW ORLEANS, LOUISIANA / ACCESS Newswire / November 12, 2025 / American Heart Association ("AHA") Conference 2025, GENinCode the predictive genetics company focused on the prevention of cardiovascular disease ("CVD"), announces the presentation by Kaiser Permanente of a major clinical utility study on CARDIO inCode-Score Polygenic Risk Score ("PRS") for the prevention of coronary heart disease ("CHD").","length":445,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":825,"height":588,"url":"https://media.zenfs.com/en/accesswire.ca/6e2131c1aa48f6dd6907d6635987acab"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/IgDoNkaf6pbN6C_LFoc5tA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY4NDtjZj13ZWJw/https://media.zenfs.com/en/accesswire.ca/6e2131c1aa48f6dd6907d6635987acab","width":825,"height":588},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/YHFgSsrnvl.UQdT97x3sfQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE2NTA7aD0xMTc2O2NmPXdlYnA-/https://media.zenfs.com/en/accesswire.ca/6e2131c1aa48f6dd6907d6635987acab","width":825,"height":588}}},{"type":"list","items":[{"val":[{"type":"text","content":"Cardiovascular disease ("CVD") is the leading cause of death in the US and worldwide with over 82 million Americans living with CVD.","length":142,"tagName":"p"}]},{"val":[{"type":"text","content":"CVD accounts for one in every three deaths in the US, or more than 900,000 deaths per year.","length":91,"tagName":"p"}]},{"val":[{"type":"text","content":"The estimated annual cost of CVD to US healthcare is over $400Bn with a consequential productivity loss of over $350Bn per annum which is forecast to exceed $1Trillion by 2035.","length":176,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":409,"olType":false},{"type":"text","content":"The presentation titled ‘Enhancing the PREVENT Equation with a Polygenic Risk Score: Clinical Utility' showed the latest ASCVD clinical prediction tool ‘PREVENT' was significantly enhanced by the inclusion of CARDIO inCode-Score (PRS), improving the predictive accuracy in personalised risk assessment for prevention of CHD.","length":332,"tagName":"p"},{"type":"text","content":"CARDIO inCode-Score is a clinically validated, commercially available...